Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises
{{output}}
Major advances in cancer treatment have emerged with the introduction of immunotherapies using blocking antibodies that target T-cell inhibitory receptors, such as programmed death-1 (PD-1) and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), known as imm... ...
